A panel of medical experts convened by the FDA urged the agency to study and adopt new standards to prohibit the use of talc in consumer products such as gum, candy, rice and pharmaceuticals. Many of the experts cited the more than 30 years of studies showing an association between talc use and ovarian cancer, which led Johnson & Johnson to remove the company’s iconic body powders from the market in recent years. Since that time, more than 40 studies have been published supporting those findings. In addition, hundreds of tests, including those conducted by the FDA, have revealed the presence of asbestos in cosmetic talc, further increasing the carcinogenic risk of any talc exposure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Trump Trade: White House announces ‘Golden Dome’ missile-defense shield
- Johnson & Johnson: FDA panel votes 6-2 in favor of Darzalex Faspro
- HHS says ‘taking immediate steps to implement’ Trump drug pricing order
- CMS demands on drug pricing ‘extreme,’ ‘highly problematic,’ says Leerink
- Sector Spotlight: Trump executive order targets drug prices